Novo Nordisk says semaglutide cut obesity rates in young children in trial
Investing.com· Reuters· Sep 7, 2026 · 11:06 AM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocks40 minutes ago
Soitec surges as JPMorgan upgrades stock, doubles price target on photonics boom
Investing.com
stocksabout 1 hour ago
FTSE 100 today: Stocks edge higher as miners rally; Beijing presses U.S.-Iran talk
Investing.com
stocksabout 1 hour ago
Why is Babcock International stock climbing today?
Investing.com